|
1
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001.PubMed/NCBI
|
|
2
|
Winawer S, Fletcher R, Rex D, et al:
Colorectal cancer screening and surveillance: clinical guidelines
and rationale-Update based on new evidence. Gastroenterology.
124:544–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Compton CC, Fielding LP, Burgart LJ, et
al: Prognostic factors in colorectal cancer. College of American
Pathologists Consensus Statement 1999. Arch Pathol Lab Med.
124:979–994. 2000.PubMed/NCBI
|
|
4
|
Guerra A, Borda F, Javier Jimenez F,
Martinez-Penuela JM and Larrinaga B: Multivariate analysis of
prognostic factors in resected colorectal cancer: a new prognostic
index. Eur J Gastroenterol Hepatol. 10:51–58. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hundt S, Haug U and Brenner H: Blood
markers for early detection of colorectal cancer: a systematic
review. Cancer Epidemiol Biomarkers Prev. 16:1935–1953. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chung KY and Kelsen D: Adjuvant therapy
for stage II colorectal cancer; who and with what? Cut Treat
Options Gastroenterol. 9:272–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Jatokoe T, Zhang Y, et al: Gene
expression profiles and molecular markers to predict recurrence of
Dukes' B colon cancer. J Clin Oncol. 22:1564–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Engell HC: Cancer cells in the circulating
blood; a clinical study on the occurrence of cancer cells in the
peripheral blood and in venous blood draining the tumor area at
operation. Ugeskr Laeger. 117:822–823. 1995.
|
|
9
|
Iinuma H, Okinaga K, Egami H, et al:
Usefulness and clinical significance of quantitative real-time
RT-PCR to detect isolated tumor cells in the peripheral blood and
tumor drainage blood of patients with colorectal cancer. Int J
Oncol. 28:297–306. 2006.PubMed/NCBI
|
|
10
|
Peach G, Kim C, Zacharakis E, Purkayastha
S and Ziprin P: Prognostic significance of circulating tumour cells
following surgical resection of colorectal cancers: a systematic
review. Br J Cancer. 102:1327–1334. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Riethdorf S, Wikman H and Pantel K:
Biological relevance of disseminated tumor cells in cancer
patients. Int J Cancer. 123:1991–2006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tol J, Koopman M, Miller MC, et al:
Circulating tumour cells early predict progression-free and overall
survival in advanced colorectal cancer patients treated with
chemotherapy and targeted agents. Ann Oncol. 21:1006–1012. 2010.
View Article : Google Scholar
|
|
13
|
Yen LC, Yeh YS, Chen CW, et al: Detection
of KRAS oncogene in peripheral blood as a predictor of the response
to cetuximab plus chemotherapy in patients with metastatic
colorectal cancer. Clin Cancer. 15:4508–4513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Bono JS, Attard G, Adjei A, et al:
Potential applications for circulating tumor cells expressing the
insulin-like growth factor-I receptor. Clin Cancer. 13:3611–3616.
2007.PubMed/NCBI
|
|
15
|
Thorsteinsson M and Jess P: The clinical
significance of circulating tumor cells in non-metastatic
colorectal cancer: a review. Eur J Surg Oncol. 37:459–465. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iinuma H, Watanabe T, Mimori K, et al:
Clinical significance of circulating tumor cells, including cancer
stem-like cells, in peripheral blood for recurrence and prognosis
in patients with Dukes' stage B and C colorectal cancer. J Clin
Oncol. 29:1547–1555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumors:accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–758. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Todaro M, Francipane MG, Medema JP and
Stassi G: Colon cancer stem cells: promise of targeted therapy.
Gastroenterology. 138:2151–2162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig
R and Kasimir-Bauer S: Stem cell and epithelial-mesenchymal
transition markers are frequently overexpressed in circulating
tumor cells of metastatic breast cancer patients. Breast Cancer
Res. 11:R462009. View
Article : Google Scholar
|
|
20
|
Balic M, Lin H, Young L, et al: Most early
disseminated cancer cells detected in bone marrow of breast cancer
patients have a putative breast cancer stem cell phenotype. Clin
Cancer. 12:5615–5621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sergeant G, Penninckx F and Topal B:
Quantitative RT-PCR detection of colorectal tumor cells in
peripheral blood: a systematic review. J Surg Res. 150:144–152.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumor
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Richardson GD, Robson CN, Lang SH, et al:
CD133, a novel marker for human prostatic epithelial stem cells. J
Cell Sci. 117:3539–3545. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lugli A, Iezzi G, Hostettler I, et al:
Prognostic impact of the expression of putative cancer stem cell
markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Br J Cancer. 103:382–390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rahbari NN, Aigner M, Thorlund K, et al:
Meta-analysis shows that detection of circulating tumor cells
indicates poor prognosis in patients with colorectal cancer.
Gastroenterology. 138:1714–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
